跳至主要内容
临床试验/NCT06611449
NCT06611449进行中(未招募)不适用

The Effect of Minimal Flow Anesthesia on Oxidative and Neuroendocrine Stress Response

Bezmialem Vakif University1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2024年6月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
2
试验地点
1
主要终点
Interleukin 6 (IL-6) level

研究概览

简要总结

Patients under general anesthesia who are unconscious and have stopped spontaneous breathing are actively ventilated with anesthesia machines, ensuring the anesthesia gas reaches the lungs and then the bloodstream. Not all the gas reaching the lungs during respiration is used; a small portion is absorbed by the body, and most of it is expelled during exhalation. After eliminating the carbon dioxide in the expired gas, it is more suitable to re-breathe the remaining gas. The portion taken by the patient needs to be provided for the next breath, and this added gas is called "fresh gas flow." Today, low flow anesthesia is defined when the fresh gas flow rate is 0.5-1 L/min, minimal flow anesthesia when it is 0.25-0.5 L/min, and metabolic flow anesthesia when it is 0.25 L/min. Our study will evaluate the effects of minimal flow anesthesia, which is widely used today due to its advantages, on oxidative stress and neuroendocrine stress response

详细描述

General anesthesia is characterized by anesthesia, analgesia, amnesia, and muscle relaxation. The most common practice today for maintaining anesthesia after induction is to add a low-density effective inhalation anesthetic to an oxygen/air mixture. Patients who are unconscious and have stopped spontaneous breathing are actively ventilated with anesthesia machines, ensuring the anesthesia gas reaches the lungs and then the bloodstream. Minute ventilation refers to the total amount of gas (oxygen, air, and anesthetic agent mixture) a patient breathes in one minute, which is approximately 5-6 L in a normal adult weighing 70 kg.

During respiration, not all the gas reaching the lungs is used; a small portion is absorbed by the body, and most of it is expelled during exhalation. After eliminating the carbon dioxide in the expired gas, it is more suitable to re-breathe the remaining gas for lung physiology, environmental protection, and cost-effectiveness. The portion taken by the patient needs to be provided for the next breath, and this added gas is called "fresh gas flow."

Today, in adults, low flow anesthesia is defined when the fresh gas flow rate is 0.5-1 L/min, minimal flow anesthesia when it is 0.25-0.5 L/min, and metabolic flow anesthesia when it is 0.25 L/min. Reducing the fresh gas flow has positive effects on the patient's health under anesthesia, environmental protection, and cost-effectiveness, as well as reducing pathologies in the operating room staff due to air pollution. Low flow anesthesia has been shown to have no adverse effects on oxygenation, ventilation, organ functions, or hemodynamic parameters. It does not affect any surgical procedure.

The acute stress response associated with surgery and anesthesia is connected to the neuroendocrine-metabolic system and the inflammatory-immune system. In response to surgical stress, adrenocorticotropic hormone(ACTH) is released from the pituitary gland via corticotropin-releasing hormone(CRH). ACTH stimulates the adrenal cortex to release glucocorticoid (cortisol). Both innate and adaptive immune cells play a role in the stress response to surgery. Cytokines mediate the local inflammatory response seen with tissue damage. Pro-inflammatory cytokines, such as interleukin-6 (IL-6), are released, peaking in the first 24 hours post-surgery.

Previous studies have shown an increase in cortisol, ACTH, and IL-6 values on the first postoperative day; their changes were recorded by measuring them at induction, the end of surgery, and at postoperative 12 and 24 hours. The body contains unstable molecules defined as free oxygen radicals. These molecules are balanced by antioxidant molecules. The imbalance in favor of oxidants leads to oxidative stress, causing a series of tissue damage. The biochemical markers indicating this balance are total antioxidant status (TAS) and total oxidative status (TOS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •• Ages 18-65
  • •Scheduled for elective septorhinoplasty
  • •ASA (physical status) 1-2

排除标准

  • •• ASA (physical status) III-IV
  • •Under 18 or over 65
  • •Pregnant individuals
  • •Serious cardiovascular disease or arrhythmia
  • •Chronic obstructive pulmonary disease
  • •Severe respiratory failure
  • •Uncontrolled cerebrovascular disease
  • •Hepatic or renal dysfunction
  • •Allergy to propofol, fentanyl, rocuronium, sevoflurane
  • •Pituitary gland disease (e.g., pituitary adenoma)
  • •Adrenal gland disease (e.g., pheochromocytoma, Cushing's disease)
  • •Immune deficiency
  • •Neuroendocrine system disease
  • •BMI > 40
  • •Patients who refuse to provide written informed consent.

研究组 & 干预措施

The minimal flow group

Active Comparator

As soon as mechanical ventilation begins, sevoflurane at a concentration of 3% and a fresh gas flow of 4 L/min with 40-45% oxygen will be used to maintain ventilation until the MAC value reaches 0.9-1.0 For patients in Group 1:the minimal flow group (n=16), maintenance anesthesia will be provided with 80-100% O2 and 3.5-4.5% sevoflurane at a fresh gas flow rate of 0.3-0.5 L/min(minimal fresh gas flow anesthesia) Near the end of the operation, the maintenance anesthetics will be discontinued, and the fresh gas flow will be increased to 6 L/min

干预措施: The minimal flow anesthesia with sevoflurane group (Other)

The high flow group

Active Comparator

As soon as mechanical ventilation begins, sevoflurane at a concentration of 3% and a fresh gas flow of 4 L/min with 40-45% oxygen will be used to maintain ventilation until the MAC value reaches 0.9-1.0 For patients in Group 2: the high flow group (n=16), maintenance anesthesia will be provided with a 40-45% oxygen-air mixture, 2-2,5% sevoflurane, and a fresh gas flow rate of 4 L/min (high fresh gas flow anesthesia) Near the end of the operation, the maintenance anesthetics will be discontinued, and the fresh gas flow will be increased to 6 L/min

干预措施: The high flow anesthesia with sevoflurane group (Other)

结局指标

主要结局

Interleukin 6 (IL-6) level

时间窗: Just before surgery begins, postoperative 6th hour and postoperative 18th hour

Proinflammatory cytokines (Biochemical marker)

Adrenocorticotropic hormone (ACTH) level

时间窗: Just before surgery begins, postoperative 6th hour and postoperative 18th hour

Adrenocorticotropic hormone(Biochemical marker)

Cortisol level

时间窗: Just before surgery begins, postoperative 6th hour and postoperative 18th hour

Biochemical marker

Total oxidative status (TOS) Level

时间窗: Just before surgery begins, end of surgery, postoperative 6th hour and postoperative 18th hour

Total oxidative status; blood biochemical tests are used to calculate oxidative indicators.

Total antioxidative status( TAS) Level

时间窗: Just before surgery begins, end of surgery, postoperative 6th hour and postoperative 18th hour

Total antioxidative status; blood biochemical tests are used to calculate oxidative indicators.

次要结局

  • amount of bleeding(end of surgery)
  • Amount of volatile anesthetic use(End of anesthesia)
  • Body temperature change(From the beginning of anesthesia to the 18th postoperative hour)
  • The presence of nausea and vomiting(From the recovery of anesthesia to the 18th postoperative hour)
  • Assessment of pain(From the recovery of anesthesia to the 18th postoperative hour)
  • Adverse events(From the recovery of anesthesia to the 18th postoperative hour)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Hilal Deniz, Dr

Resident Doctor

Bezmialem Vakif University

研究点 (1)

Loading locations...

相似试验